Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Soft inquiries are often used in prequalification. This article outlines when they occur and how they affect your credit profile.
10,144 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
When a tech titan backs a biotech startup, investors take note. This article digs into whether Jeff Bezos backed Grai...
Astera Labs stands at an inflection point: rapid AI demand could lift the stock, but margin pressures and a premium v...
A sharp intraday drop in Micron shares sparked by AI memory demand concerns set off a broader discussion about pricin...
A federal jury in San Francisco ruled that Elon Musk misled Twitter investors ahead of the 2022 buyout, setting up a ...
A real-world tale shows how impersonation allegations can ripple into large Medicaid overpayments. Learn how to prote...
SoundHound AI reports a 59% rise in Q4 revenue and a narrowed EBITDA loss, yet the stock has fallen year-to-date amid...
Sirius XM stunned investors with a near-50% rise in the first half of 2026. This analysis breaks down the catalysts, ...
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
SpaceX is one of the most anticipated names in tech and aerospace. This guide shows everyday investors how to beat wa...
A tariff surge prompts a Monopoly game importer to rethink domestic production. The move highlights the cost, time an...